ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • LIC IPO
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Bitbns
  • Marksmen 2022
  • More ...
    • VIDEOS
    • PHOTOS
    • MARKSMEN 2022
BREAKING NEWS
  • LIC IPO: At Rs 5.54 lakh cr market cap on BSE, state-run insurer becomes 5th largest company on debut
  • Dalal Street Corner: Metals, broader markets help bulls take control; what should investors do on Wednesday?
  • What makes LIC shares good dividend, long-term play? Experts decode
  • SC extends demolition deadline of Supertech’s twin towers till 28 August
  • Apple AirPods, MagSafe chargers likely to come with USB Type-C port - Check details
Read in App
Business News » Companies News

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Glenmark Pharma gets USFDA nod for cholesterol lowering drug
Citing IQVIA sales data, Glenmark said Vytorin tablets' market achieved annual sales of approximately USD 92.4 million for the 12-month period ended April 2019. Image source: www.glenmarkpharma.com

Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood.

The approved product is a generic version of MSD International's Vytorin tablets. The approval has been granted by the the United States Food and Drug Administration (USFDA) for for Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement.

Citing IQVIA sales data, Glenmark said Vytorin tablets' market achieved annual sales of approximately USD 92.4 million for the 12-month period ended April 2019.

The company said its current portfolio consists of 157 products authorised for distribution in the US and 58 ANDAs pending approval with the USFDA. Shares of Glenmark Pharma were trading 0.55 per cent higher at Rs 450.80 apiece on BSE.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Glenmark PharmaGlenmark PharmaceuticalsUSFDA approvalHealthcarePharma
Written By: PTI
Updated: Fri, Jun 28, 2019
02:58 pm
New Delhi, PTI
RELATED NEWS
Glenmark Pharmaceuticals gets USFDA nod for generic antibiotic cream Glenmark Pharmaceuticals gets USFDA nod for generic antibiotic cream
Pick Of The Week: In chat with Market Guru Anil Singhvi, stock analysts choose THESE shares for bumper returns Pick Of The Week: In chat with Market Guru Anil Singhvi, stock analysts choose THESE shares for bumper returns
Top Stocks to Buy – Analyst Sandeep Jain picks Glenmark Pharma, Nilkamal, VST Industries for top gains; Know what make them his Monday picks Top Stocks to Buy – Analyst Sandeep Jain picks Glenmark Pharma, Nilkamal, VST Industries for top gains; Know what make them his Monday picks

LATEST NEWS

Dalal Street Corner: Metal index, broader markets help bulls take control as benchmarks extend gains for 2nd day; what should investors do on Wednesday?

Bharti Airtel Q4 Results 2022: PAT jumps 164% YoY at Rs 2008 cr on higher ARPU; company announces dividend of Rs 3

IPO Watch: LIC IPO, Paytm, Coal India and SBI Card - some big IPOs and their performance after listing

LIC IPO: At Rs 5.54 lakh cr market cap on BSE, state-run insurer becomes 5th largest company on debut

Want to change UPI pin of your Google Pay app? Here's step by step guide

Elon Musk hints paying less for Twitter as he fights with Parag Agrawal over bots

Sony PlayStation Plus subscription coming soon - Here's all you need to know

LIC is world’s cheapest insurance stock in terms of valuations: Zee Business research report

Economy likely to grow 12-13% in Q1, annual GDP projection at 7.2, says Icra

Q4 Results 2022: DLF Q4 profit declines 16% to Rs 405.33 cr; Abbott India Q4 net up 39% at Rs 211 cr

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2022. India Dot Com Private Limited. All Rights Reserved.
LIVE TV